These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20839343)

  • 1. The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia.
    Salerno E; Yuan Y; Scaglione BJ; Marti G; Jankovic A; Mazzella F; Laurindo MF; Despres D; Baskar S; Rader C; Raveche E
    Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S98-109. PubMed ID: 20839343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL).
    Kasar S; Underbayev C; Hassan M; Ilev I; Degheidy H; Bauer S; Marti G; Lutz C; Raveche E; Batish M
    PLoS One; 2016; 11(3):e0149331. PubMed ID: 26959643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity.
    Salerno E; Scaglione BJ; Coffman FD; Brown BD; Baccarini A; Fernandes H; Marti G; Raveche ES
    Mol Cancer Ther; 2009 Sep; 8(9):2684-92. PubMed ID: 19723889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia.
    Underbayev C; Kasar S; Ruezinsky W; Degheidy H; Schneider JS; Marti G; Bauer SR; Fraidenraich D; Lightfoote MM; Parashar V; Raveche E; Batish M
    Oncotarget; 2016 Sep; 7(38):60986-60999. PubMed ID: 27533467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.
    Raveche ES; Salerno E; Scaglione BJ; Manohar V; Abbasi F; Lin YC; Fredrickson T; Landgraf P; Ramachandra S; Huppi K; Toro JR; Zenger VE; Metcalf RA; Marti GE
    Blood; 2007 Jun; 109(12):5079-86. PubMed ID: 17351108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
    Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
    Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia.
    Kasar S; Salerno E; Yuan Y; Underbayev C; Vollenweider D; Laurindo MF; Fernandes H; Bonci D; Addario A; Mazzella F; Raveche E
    Genes Immun; 2012 Feb; 13(2):109-19. PubMed ID: 21881595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4.
    Ma S; Shukla V; Fang L; Gould KA; Joshi SS; Lu R
    J Biol Chem; 2013 Sep; 288(37):26430-40. PubMed ID: 23897826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.
    Scaglione BJ; Salerno E; Balan M; Coffman F; Landgraf P; Abbasi F; Kotenko S; Marti GE; Raveche ES
    Br J Haematol; 2007 Dec; 139(5):645-57. PubMed ID: 17941951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cultured malignant B-1 line serves as a model for Richter's syndrome.
    Peng B; Sherr DH; Mahboudi F; Hardin J; Wu YH; Sharer L; Raveché ES
    J Immunol; 1994 Aug; 153(4):1869-80. PubMed ID: 8046247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NZB mouse as a model for chronic lymphocytic leukemia.
    Phillips JA; Mehta K; Fernandez C; Raveché ES
    Cancer Res; 1992 Jan; 52(2):437-43. PubMed ID: 1370214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of host environment on growth of clonal CD5+B (Lyl+B) cells.
    Raveche ES; Lin TZ; Conroy J; Tjio JH; Steinberg AD; Rudolfsky UA; Phillips JA
    Autoimmunity; 1991; 10(3):217-25. PubMed ID: 1721848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model.
    Rebolleda N; Losada-Fernandez I; Perez-Chacon G; Castejon R; Rosado S; Morado M; Vallejo-Cremades MT; Martinez A; Vargas-Nuñez JA; Perez-Aciego P
    PLoS One; 2016; 11(4):e0154159. PubMed ID: 27101369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages.
    Okamoto H; Nishimura H; Shinozaki A; Zhang D; Hirose S; Shirai T
    Jpn J Cancer Res; 1993 Dec; 84(12):1273-8. PubMed ID: 7507474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered CD45 expression in malignant B-1 cells.
    Dang AM; Phillips JA; Lin T; Raveche ES
    Cell Immunol; 1996 May; 169(2):196-207. PubMed ID: 8620547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential roles of miR-15a/16-1 and miR-497/195 clusters in immune cell development and homeostasis.
    Hutter K; Rülicke T; Drach M; Andersen L; Villunger A; Herzog S
    FEBS J; 2021 Mar; 288(5):1533-1545. PubMed ID: 32705746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of a lymphoproliferative disorder in aged NZB mice.
    Marti GE; Metcalf RA; Raveche E
    Curr Top Microbiol Immunol; 1995; 194():117-26. PubMed ID: 7895486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered response to and production of TGF-beta by B cells from autoimmune NZB mice.
    Douglas RS; Woo EY; Capocasale RJ; Tarshis AD; Nowell PC; Moore JS
    Cell Immunol; 1997 Aug; 179(2):126-37. PubMed ID: 9268496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice.
    Scaglione BJ; Salerno E; Gala K; Pan M; Langer JA; Mostowski HS; Bauer S; Marti G; Li Y; Tsiagbe VK; Raveche ES
    J Autoimmun; 2009 Feb; 32(1):14-23. PubMed ID: 19022624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression.
    Santanam U; Zanesi N; Efanov A; Costinean S; Palamarchuk A; Hagan JP; Volinia S; Alder H; Rassenti L; Kipps T; Croce CM; Pekarsky Y
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12210-5. PubMed ID: 20566844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.